Tiziana Life Sciences (TLSA) Current Assets (2017 - 2025)

Tiziana Life Sciences has reported Current Assets for 9 years, with the latest figure at $8.6 million in Q4 2025.

• On a quarterly basis, Current Assets rose 13.91% year-over-year to $8.6 million in Q4 2025; TTM through Dec 2025 was $8.6 million, a 13.91% increase from a year earlier, with the FY2025 full-year figure at $8.6 million, up 13.91% from the prior year.
• Current Assets was $8.6 million for Q4 2025 at Tiziana Life Sciences, down from $12.7 million in the prior quarter.
• The five-year high for Current Assets was $57.2 million in Q2 2021, with the low at $7.3 million in Q4 2023.
• Average Current Assets over 5 years is $22.1 million, with a median of $13.9 million recorded in 2023.
• The sharpest annual moves came in 2021 and 2023: Current Assets surged 373.24% in 2021, then plunged 69.78% in 2023.
• Over 5 years, Current Assets stood at $48.7 million in 2021, then slumped by 50.12% to $24.3 million in 2022, then slumped by 69.78% to $7.3 million in 2023, then advanced by 2.33% to $7.5 million in 2024, then advanced by 13.91% to $8.6 million in 2025.
• The last three Current Assets figures came in at $8.6 million (Q4 2025), $12.7 million (Q2 2025), and $7.5 million (Q4 2024), per Business Quant data.